Researchers develop new strategy to target KRAS mutant cancer

In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

Researchers develop new strategy to target KRAS mutant cancer

Although KRAS is one of the major oncogenes associated with aggressive cancers, drugs designed to block KRAS function have not been able to halt cancer progression in a clinical setting. Until ...

Thu 14 Sep 17 from Medical Xpress

Researchers develop new strategy to target KRAS mutant cancer, Thu 14 Sep 17 from Eurekalert

  • Pages: 1

Bookmark

Bookmark and Share